Decheng Capital Global Life Sciences Fund IV, L.P.
Insider CIK 1834150 · AARD 10% owner · CGON 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AARD Aardvark Therapeutics, Inc | C Conversion deriv | 2025-02-14 | 2025-02-19 | 2,825,337 | — | $0 | 0 | SEC↗ |
| AARD Aardvark Therapeutics, Inc | C Conversion deriv | 2025-02-14 | 2025-02-19 | 19,777,363 | — | $0 | 0 | SEC↗ |
| AARD Aardvark Therapeutics, Inc | C Conversion | 2025-02-14 | 2025-02-19 | 333,412 | — | $0 | 333,412 | SEC↗ |
| AARD Aardvark Therapeutics, Inc | P Buy | 2025-02-14 | 2025-02-19 | 625,000 | $16.00 | $10.00M | 2,958,887 | SEC↗ |
| AARD Aardvark Therapeutics, Inc | P Buy | 2025-02-14 | 2025-02-19 | 625,000 | $16.00 | $10.00M | 958,412 | SEC↗ |
| AARD Aardvark Therapeutics, Inc | C Conversion | 2025-02-14 | 2025-02-19 | 2,333,887 | — | $0 | 2,333,887 | SEC↗ |
| CGON CG Oncology, Inc. | P Buy | 2024-01-29 | 2024-04-09 | 400,000 | $19.00 | $7.60M | 4,958,810 | SEC↗ |
| CGON CG Oncology, Inc. | C Conversion deriv | 2024-01-29 | 2024-01-31 | 21,547,685 | — | $0 | 0 | SEC↗ |
| CGON CG Oncology, Inc. | C Conversion deriv | 2024-01-29 | 2024-01-31 | 4,402,320 | — | $0 | 0 | SEC↗ |
| CGON CG Oncology, Inc. | C Conversion deriv | 2024-01-29 | 2024-01-31 | 8,644,891 | — | $0 | 0 | SEC↗ |
| CGON CG Oncology, Inc. | P Buy | 2024-01-29 | 2024-01-31 | 400,000 | $19.00 | $7.60M | 400,000 | SEC↗ |
| CGON CG Oncology, Inc. | C Conversion | 2024-01-29 | 2024-01-31 | 3,628,198 | — | $0 | 4,558,812 | SEC↗ |